Septic Shock In A Patient With Diabetic Ulcer Complicated By Acute Kidney Failure

Ade Laksono; Agrietia Agrietia

Authors

Ade Laksono RS Tasik Medika Citratama Kota Tasikmalaya
Agrietia Agrietia RS Tasik Medika Citratama Kota Tasikmalaya

Keywords:

Sepsis, Septic Shock, Management of sepsis

Abstract

Sepsis is the main cause of death in critically ill patients treated in intensive care units and inpatient rooms. Sepsis is defined as a life-threatening organ dysfunction caused by an uncontrolled host response due to infection. The principles of sepsis therapy consist of fluid resuscitation and hemodynamic support, antibiotics and source control, and a series of adjunctive measures. Inadequate initial treatment of sepsis and septic shock will increase the mortality rate.

Author Biographies

Ade Laksono, RS Tasik Medika Citratama Kota Tasikmalaya

Agrietia Agrietia, RS Tasik Medika Citratama Kota Tasikmalaya

References

Y. Mehta and G. Kochhar, “Sepsis and septic shock,” J. Card. Crit. Care TSS, vol. 1, no. 01, pp. 3–5, 2017.

R. C. Bone, “The pathogenesis of shock,” Ann Intern Med, vol. 115, pp. 457–469, 1991.

F. LevyMM, “2001SCCM,” ESICM/ACCP/ATS/SISInternationalSepsisDefinitionsConferenceCritCareMed, 2003 …, 2003.

M. Singer et al., “The third international consensus definitions for sepsis and septic shock (Sepsis-3),” Jama, vol. 315, no. 8, pp. 801–810, 2016.

F. B. Mayr, S. Yende, and D. C. Angus, “Epidemiology of severe sepsis,” Virulence, vol. 5, no. 1, pp. 4–11, 2014.

A. Álvaro-Meca et al., “Epidemiological trends of sepsis in the twenty-first century (2000–2013): an analysis of incidence, mortality, and associated costs in Spain,” Popul. Health Metr., vol. 16, no. 1, pp. 1–11, 2018.

C. Kopitkó, L. Medve, and T. Gondos, “The value of combined hemodynamic, respiratory and intra-abdominal pressure monitoring in predicting acute kidney injury after major intraabdominal surgeries,” Ren. Fail., vol. 41, no. 1, pp. 150–158, 2019.

H. B. Nguyen et al., “Severe sepsis and septic shock: review of the literature and emergency department management guidelines,” Ann. Emerg. Med., vol. 48, no. 1, pp. 54-e1, 2006.

A. Purcarea and S. Sovaila, “Sepsis, a 2020 review for the internist,” Rom. J. Intern. Med., vol. 58, no. 3, pp. 129–137, 2020.

G. R. Bernard et al., “Efficacy and safety of recombinant human activated protein C for severe sepsis,” N. Engl. J. Med., vol. 344, no. 10, pp. 699–709, 2001.

M. M. Levy, L. E. Evans, and A. Rhodes, “The surviving sepsis campaign bundle: 2018 update,” Intensive Care Med., vol. 44, pp. 925–928, 2018.

I. A. S. Putra, “Update tatalaksana sepsis,” Cermin Dunia Kedokt., vol. 46, no. 11, pp. 681–685, 2020.

R. P. Dellinger et al., “Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012,” Intensive Care Med., vol. 39, pp. 165–228, 2013.

M. M. Levy et al., “COUNTERPOINT: should the Surviving Sepsis Campaign guidelines be retired? No,” Chest, vol. 155, no. 1, pp. 14–17, 2019.